Title : Novel glucose-lowering drugs for non-alcoholic fatty liver disease.

Pub. Date : 2021 Jan 15

PMID : 33520110






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compared with placebo or other active glucose-lowering drug treatment, treatment with DPP-4 inhibitors, GLP-1 RAs, and SGLT2 inhibitors all led to a significant decrease in ALT change and AST change from baseline. Glucose dipeptidyl peptidase 4 Homo sapiens